World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT00367562
Date of registration: 22/08/2006
Prospective Registration: No
Primary sponsor: Hospital Britanico
Public title: Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy
Scientific title: Phase IV Open Label Uncontrolled Trial of the Dual Blockade of the Renin Angiotensin System With Enalapril Plus Valsartan Combined With Oral Methylprednisolone for the Treatment of Proteinuria in IGA Nephropathy
Date of first enrolment: January 1996
Target sample size: 20
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00367562
Study type:  Interventional
Study design:  Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment  
Phase:  Phase 4
Countries of recruitment
Argentina
Contacts
Name:     hernan trimarchi, M.D.
Address: 
Telephone:
Email:
Affiliation:  Hospital Britanico
Key inclusion & exclusion criteria

Inclusion Criteria:

- PATIENTES WITH IGA NEPHROPATHY WITH PROTEINURIA OVER 0.5 G/DAY

Exclusion Criteria:

- MALIGNANCY, RENAL FAILURE



Age minimum: 21 Years
Age maximum: 70 Years
Gender: Both
Health Condition(s) or Problem(s) studied
IGA Nephropathy
Intervention(s)
Drug: ENALAPRIL VALSARTAN METHYLPREDNISONE
Primary Outcome(s)
DAILY PROTEINURIA
Secondary Outcome(s)
RENAL FUNCTION AS ASSESSED BY SERUM CREATININE
Secondary ID(s)
TEREKOWA33
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history